| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 1,250 | $15.10 | $18,875.00 | -21.6% | |
| May 24, 2016 | Dahiyat Bassil I74 | President And CEO | Sale+OE | 45,886 | $13.00 | $596,522.59 | -12.8% | |
| Apr 7, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 3,750 | $15.00 | $56,250.00 | -45.3% | |
| Mar 17, 2016 | Dahiyat Bassil I74 | President And CEO | Sale+OE | 45,886 | $11.02 | $505,553.59 | -15.9% | |
| Mar 3, 2016 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sale+OE | 14,260 | $12.01 | $171,226.95 | -12.9% | |
| Feb 1, 2016 | Stafford John S III | 10% Owner | Sell | 25 | $10.79 | $269.75 | -100% | |
| Jan 29, 2016 | Stafford John S III | 10% Owner | Buy | 25 | $10.83 | $270.75 | New | |
| Jan 4, 2016 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sale+OE | 1,100 | $14.13 | $15,538.05 | -3.9% | |
| Dec 17, 2015 | Kuch John J68 | Vice President, Finance | Sell | 4,781 | $14.89 | $71,169.49 | -31.0% | |
| Dec 16, 2015 | Foster Paul A | Chief Medical Officer | Sale+OE | 6,025 | $15.01 | $90,435.25 | -62.6% |